Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: A beneficial strategy to combat non-small cell lung cancer

Yaara Gorzalczany, Yuval Gilad, Dina Amihai, Ilan Hammel, Ronit Sagi-Eisenberg, Ofer Merimsky
  • Cancer Letters, November 2011, Elsevier
  • DOI: 10.1016/j.canlet.2011.07.002

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.canlet.2011.07.002

The following have contributed to this page: Ilan Hammel and Yuval Gilad